Antibody in asthma treatment –
Correct Answer: Omalizumab
Description: Omalizumab is a blocking antibody that neutralises circulating IgE without binding to cell-bound IgE ,and ,thus inhibits IgE mediated reactions in asthma.Patients should be given a 3 to 4 month trial of therapy to show objective benefit.Omalizumab is usually given as a subcutaneous injection every 2-4 weeks and appears not to have significant side effects,although anaphylaxis is very occasionally seen. Reference:Harrison's medicine-18th edition,page no:2112.
Category:
Medicine
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now